Latest News about GSK
Recent news which mentions GSK
Tech Titans Microsoft, Apple Lead 'Magnificent Seven' Earnings Wave This Week: Can Mega-Caps Ignite Market Optimism?
January 29, 2024
From Benzinga
A Look Into GSK Inc's Price Over Earnings
January 26, 2024
From Benzinga
GSK Cuts More Stake In Its Spun-Off Consumer-Healthcare Business Haleon, Raises Over £900M
January 17, 2024
From Benzinga
Pfizer's Aggressive Stance In Obesity Drugs: CEO Albert Bourla Confirms Bold Bet Despite Prior Drug Hurdles
January 09, 2024
From Benzinga
From Benzinga
Strides Toward Lower Drug Costs: Florida Becomes First To Receive Nod To Import Prescription Drugs from Canada
January 05, 2024
From Benzinga
Why Biopharmaceutical Player CureVac Shares Are Rising Today
January 05, 2024
From Benzinga
Sleeper Hits: 3 Unexpected Stocks Poised for a Breakout in 2024
January 05, 2024
From InvestorPlace
From Benzinga
Verona Pharma's Promising COPD Treatment Puts It in GSK's Acquisition Crosshairs, Analysts Predict Big Moves
December 29, 2023
From Benzinga
Expensive Drugs For Americans In 2024? Drugmakers Including Pfizer, Sanofi Mull Price Increase In January
December 29, 2023
From Benzinga
Pharmaceutical Giants Brace for Showdown as Medicare Drug Price Negotiations Are Poised For 2024
December 28, 2023
From Benzinga
3 Growth at a Reasonable Price (GARP) Stocks for Balanced Growth
December 22, 2023
From InvestorPlace
From Benzinga
COVAX Global Initiative For COVID-19 Vaccines Comes To An End Amid Shift To Regular Programs
December 20, 2023
From Benzinga
GSK's Jemperli Cancer Drug Hits Primary Goal In Endometrial Cancer Study
December 18, 2023
Tickers
GSK
From Benzinga
3 Machine Learning Stocks to Turn $10,000 Into $1 Million: December 2023
December 14, 2023
From InvestorPlace
From Benzinga
Competition and Optimism: GSK's CEO Walmsley Foresees Growth Despite Competition In RSV Vaccine Market
November 30, 2023
Tickers
GSK
From Benzinga
3 Stocks to Sell for Tax Losses Before the New Year
November 28, 2023
From InvestorPlace
3 Great Foreign Companies to Invest in Right Now
November 27, 2023
From Motley Fool
GSK Frames A Comeback For Its Multiple Myeloma Drug Following Encouraging Phase 3 Data
November 27, 2023
Tickers
GSK
From Benzinga
Merck's Latest Drug For Chronic Cough Faces FDA Pushback
November 18, 2023
From Benzinga
Senator's Bearish Tesla Bet Under Scrutiny As He Buys Put Options Ahead Of Elon Musk-Led Company's Q3 Results That Set Stock Slide In Motion
November 17, 2023
From Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.